Imbio's platform looks like it would seamlessly fold into 4DX's, very similar model. They're cash-flow positive, have distribution/partner channels already established with major medical imaging companies (link), and something I think is a real kicker, they've got FDA 510(k) clearance for a cardiothoracic imaging algorithm (link).
This acquisition could open a lot of doors for US/EU distribution using Imbio's pre-established connections, AND this could start 4DX's expansion from its current respiratory-focused pipeline into other areas, as AF has previously mentioned.
Ann: Trading Halt, page-22
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
-0.050(8.62%) |
Mkt cap ! $217.5M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 57.5¢ | 52.5¢ | $945.4K | 1.730M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 151700 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 55780 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |